The Institute for Innovation & Valuation in Health Care, InnoValHC, is an independent not-for-profit research organization. It was established by scientists with medical, health economic, and econometric backgrounds, as well as hands-on management experience, to analyze the economic dimension of health and health care, including research into the normative foundations and the methods of health economics, applied cost of illness and cost benefit studies, and their use in Health Technology Assessment (HTA).
Pharma Pricing & Access Innovation Conference 2025
Michael Schlander will speak about ´Early Strategic Decision Making in Drug Development: The Role of Health Economics for Market Access´ at the PPIC in Basel / Switzerland (June 3-5, 2025).
Read more … Pharma Pricing & Access Innovation Conference 2025
Measuring the Socioeconomic Impact of Cancer
Discussion paper on measuring the socioeconomic impact of cancer based on a systematic review and standardized assessment of patient-reported outcome (PRO) instruments.
Summer School 2024 Evaluation Report
For the first time, the Heidelberg Health Economics Summer School took place in the picturesque Italian Dolomites (Bruneck-Brunico / September 20-27, 2024). The Evaluation Report is now available and can be downloaded.
New Health Economic Perspectives
Michael Schlander presented and discussed the topic "Health Technology Assessment (HTA): New Health Economic Perspectives" at the EuHEA Conference 2024 in Vienna, Austria / June 30 - July 03, 2024.
